Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemia

by Eiring, Anna M, Deininger, Michael W
Published 2014

Advances in the treatment of chronic myeloid leukemia

by Eiring, Anna M, Khorashad, Jamshid S, Morley, Kimberly, Deininger, Michael W
Published 2011

New concepts for CML clonality

by Khorashad, Jamshid S., Deininger, Michael W., O'Hare, Thomas
Published 2013

Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1

by Zabriskie, Matthew S., Vellore, Nadeem A., Gantz, Kevin C., Deininger, Michael W., O’Hare, Thomas
Published 2015

A Coiled-Coil Mimetic Intercepts BCR-ABL1 Dimerization in Native and Kinase-Mutant Chronic Myeloid Leukemia

by Woessner, David W., Eiring, Anna M., Bruno, Benjamin J., Zabriskie, Matthew S., Reynolds, Kimberly R., Miller, Geoffrey D., O’Hare, Thomas, Deininger, Michael W., Lim, Carol S.
Published 2015

Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies

by Sonnichsen, Daryl, Dorer, David J., Cortes, Jorge, Talpaz, Moshe, Deininger, Michael W., Shah, Neil P., Kantarjian, Hagop M., Bixby, Dale, Mauro, Michael J., Flinn, Ian W., Litwin, Jeffrey, Turner, Christopher D., Haluska, Frank G.
Published 2013

RAPID CONVERSION OF CHRONIC MYELOID LEUKEMIA TO CHRONIC MYELOMONOCYTIC LEUKEMIA IN A PATIENT ON IMATINIB THERAPY

by Khorashad, Jamshid S., Tantravahi, Srinivas K., Yan, Dongqing, Mason, Clinton C., Qiao, Yi, Eiring, Anna M., Gligorich, Keith, Hein, Than, Pomicter, Anthony D., Reid, Alistair G., Kelley, Todd W., Marth, Gabor T., O'Hare, Thomas, Deininger, Michael W.
Published 2016

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

by Eiring, Anna M., Khorashad, Jamshid S., Anderson, David J., Yu, Fan, Redwine, Hannah M., Mason, Clinton C., Reynolds, Kimberly R., Clair, Phillip M., Gantz, Kevin C., Zhang, Tian Y., Pomicter, Anthony D., Kraft, Ira L., Bowler, Amber D., Johnson, Kara, Mac Partlin, Mary, O’Hare, Thomas, Deininger, Michael W.
Published 2015

Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-Resistant Chronic Myeloid Leukemia

by Eiring, Anna M., Page, Brent D. G., Kraft, Ira L., Mason, Clinton C., Vellore, Nadeem A., Resetca, Diana, Zabriskie, Matthew S., Zhang, Tian Y., Khorashad, Jamshid S., Engar, Alexander J., Reynolds, Kimberly R., Anderson, David J., Senina, Anna, Pomicter, Anthony D., Arpin, Carolynn C., Ahmad, Shazia, Heaton, William L., Tantravahi, Srinivas K., Todic, Aleksandra, Moriggl, Richard, Wilson, Derek J., Baron, Riccardo, O'Hare, Thomas, Gunning, Patrick T., Deininger, Michael W.
Published 2014

Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance

by Yoda, Akinori, Adelmant, Guillaume, Tamburini, Jerome, Chapuy, Bjoern, Shindoh, Nobuaki, Yoda, Yuka, Weigert, Oliver, Kopp, Nadja, Wu, Shuo-Chieh, Kim, Sunhee S., Liu, Huiyun, Tivey, Trevor, Christie, Amanda L., Elpek, Kutlu G., Card, Joseph, Gritsman, Kira, Gotlib, Jason, Deininger, Michael W., Makishima, Hideki, Turley, Shannon J., Javidi-Sharifi, Nathalie, Maciejewski, Jaroslaw P., Jaiswal, Siddhartha, Ebert, Benjamin L., Rodig, Scott J., Tyner, Jeffrey W., Marto, Jarrod A., Weinstock, David M., Lane, Andrew A.
Published 2014